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Abstract 
Amino acids, the essential building blocks of life are important to study the genetic diseases, modelling of protein structure and 
also in drug designing. A PCA model along with signal processing technique is used here for differentiating the prostate cancer 
cells from normal prostate cells. The amino acid sequence of cells is taken as input sample for the PCA technique. The model is 
successfully tested on 8 normal and 8 cancerous Homo sapiens prostate cells. 
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1. Introduction 
Nowadays researchers from various cross fields have concentrated their research in genomic study which is 
mainly information extraction and data analysis. Generally, two broadly classified research areas of genomics are 
DNA sequence analysis and disease diagnosis [1]. DNA sequence analysis is a well developed research area used to 
reveal hidden features present in protein coding regions whereas diagnosis of disease is used to find out 
abnormalities present in DNA sequence because almost all the genetic diseases, such as Parkinson, Alzheimer, 
Cancer and development of abnormalities are characterized by the presence of genetic variations. Due to occupying 
the leading position for causing worldwide death of men and women over few decades, Cancer is able to create great 
queries among the researchers in the recent time and significant discoveries has made to provide better 
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understanding of genetic basis of cancer. Amino acids of DNA which are essential to form antibodies to combat 
bacteria and viruses; they are the part of the enzyme and hormonal system play a significant role in cancer research. 
Controlled Amino Acid Therapy (CAAT) is an efficient medical treatment used to impair the development of cancer 
cell [2]. It has been understood from medical research reports, out of the all cancers, prostate cancer is most common 
among adult men all over the world and Prostate Screening Antigen (PSA) test is used for the patients to measure the 
protein level produced by prostate gland [3]. 
It is well known that twenty amino acids of a DNA sequence are responsible for the formation of protein [4]. In 
this present scenario, the study of amino acids and proteins are important to understand the genetic basis of cancer. 
The authors in this paper have made a comparative study between prostate cancer and normal prostate Homo sapiens 
cells based on their amino acids sequence databases. Principal Component Analysis (PCA) , a powerful statistical 
technique which reduces large input vectors without much loss of information is chosen here for comparative study, 
as the Homo Sapiens databases consist of long string of amino acids . A Principal Component Analysis (PCA) model 
has been designed, followed by Discrete Fourier transform of mapped amino acid sequence for the analysis. The 
method is successfully tested on Homo Sapiens prostate databases available in public domain [18]. The paper is 
organized into number of sections: Introduction, Brief Background, Methodology, Results and Discussion and 
Conclusions. 
2. Brief Background 
The story of life starts from cell and DNA is important to all cells and organisms because an organism could do 
nothing without DNA [5]. A mutation is the permanent change in the DNA, can arise spontaneously with apparent 
cause and can lead to cell death, cell alteration, cell formation or in some cases development of cancer cells [6]. 
    A DNA, an informational molecule encoding the genetic information, encoded as a sequence of nucleotide bases: 
guanine (G), adenine (A), thymine (T) and cytosine (C) and divided into two regions: Genes and Inter-genic spaces. 
A gene also can be dividing into two sub-regions named Exon (coding region) and Intron (non-coding region) 
(Fig.1). Exons of a DNA sequence are the most information bearing part because only the exons take part in protein 
coding while the introns are spliced off during protein synthesis. In exon region the bases are divide into three 
adjacent bases called codon which translated into amino acid and 64 possible codons generate 20 amino acids 










                                            
Fig.1. (a) DNA sequence; (b) A DNA sequence showing genes and intergenic regions.  
The study of amino acids in a protein sample presents a new horizon for cancer classification and prediction. 
Some amino acids are essential for the growth of tumor cells and restricting them or inhibiting them may be 
beneficial for curing cancer patients[4]. Digital Signal Processing (DSP) can be effectively used in genomics study 
with great accuracy as Genomic or Proteomic information is digital in nature. In this present paper, Discrete Fourier 
Transform (DFT) is used for spectrum estimation of cells and a PCA model is designed for comparative analysis of 
normal and cancer cells. 
 
3. Methodology 
     The application of Fourier transform techniques has found to be very useful for both DNA and amino acids 
sequences. DSP techniques is applicable only to numerical data but the amino acids consist of alphabets A, C, D, E, 
F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y [7,8,9]. Hence, a mapping technique is required to convert the 
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alphabetic sequence into numerical sequence before applying DSP. Here a well known single sequence electron ion 
interaction pseudo potential (EIIP) mapping rule [10], based on the distribution of free electron's energy along DNA 
sequence is used for the conversion. The EIIP values of 20 amino acids are displayed in [Table.1]. 
 
Suppose, an amino acid chain of a cell is: x[n] =  [M P I G S K E R P T F D]; 
After EIIP mapping using Table 1: 
x[n] = [0.0373 0.0198 0.0000 0.0050 0.0829 0.0371 0.0058 0.0959 0.0198 0.0941 0.0946 0.1263]; 
 
        Table 1. List of 20 amino acids with codons and EIIP values. 
 
 

















After this conversion, spectral estimation of EIIP mapped sequence is obtained by using Discrete Fourier 
Transform (DFT) technique. PCA, a standard tool for multivariate data analysis [11-13] is used to generate 
maximum uncorrelated components called Principal Components (PC) between the prostate cancer and normal 
prostate cells. The block representation of the PCA model for comparative analysis is depicted in Fig.2. and the 










                                                                       Fig.2. PCA model for comparative study. 
 
 
 Step 1:  Convert the scanned amino acid sequence into numerical form using EIIP values and compute DFT of the  
 converted sequence using these equations:  
               Let, x(n) = a normal prostate cell  (taken as reference) 
               y(n) = a normal or cancer prostate cell (taken as target) 
              The DFT of the EIIP sequence is given by: 
Sl. No Abbreviation Amino Acid Codons EIIP Value 
1 A Ala Alanine GCA,GCC,GCG,GCT 0.0373 
2 C Cys Cystein (has S) TGC,TGT 0.0829 
3 D Asp Aspartic Acid GAC,GAT 0.1263 
4 E Glu Glutamic Acid GAA,GAG 0.0058 
5 F Phe Phenylalanine TTC,TTT 0.0946 
6 G Gly Glycine GGA,GGC.GGG,GGT 0.0050 
7 H His Histidine CAC,CAT 0.0242 
8 I Ile Isoleucine ATA,ATC,ATT 0.0000 
9 K Lys Lysine AAA,AAG 0.0371 
10 L Leu Leucine TTA,TTG,CTA,CTC,CTG,CTT 0.0000 
11 M Met Methionine ATG 0.0823 
12 N Asn Asparagine AAC,AAT 0.0036 
13 P Pro Proline CCA,CCC,CCG,CCT 0.0198 
14 Q Gln Glutamine CAA,CAG 0.0761 
15 R Arg Arginine AGA,AGG,CGA,CGC,CGG,CGT 0.0959 
16 S Ser Serine AGC,AGT,TCA,TCC,TCG,TCT 0.0829 
17 T Thr Threonine ACA,ACC,ACG,ACT 0.0941 
18 V Val Valine GTA,GTC,GTG,GTT 0.0057 
19 W Trp Tryptophan TGG 0.0548 
20 Y Tyr Tyrosine TAC,TAT 0.0516 
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                
n
NnkjenxkXs /2][][          (1) 
               |][|][ kXskX             (2) 
 
               XS[k] = DFT of reference sequence; YS[k]= DFT of target sequence; 
                  X[k] = Amplitude spectrum of XS[k];   
         Similarly, Y[k] = Amplitude spectrum of YS[k];   
         N = Length of DNA sequence;              k= 0, 1, 2, …, N-1 ; n= 0, 1, 2, …, N-1 
Step 2: Convert X[k] and Y[k] into column matrix and obtain the mean value of X[k] and Y[k]: 
               ][kXX       ;    ][kYY            (3) 
Step 3: For PCA to work properly, subtract the mean from each data dimensions. The mean subtracted is  
             the average across each dimension. This produces a data set whose mean is zero. 
 
                 XkXX new      ;     YkYYnew  ][          (4) 
Step 4: To find out correlation, compute covariance matrix between reference and target sequence: 
             Covariance matrix =   newnew YXA ,cov        (5) 
                                                        = 
   








Step 5: Calculate the eigen-values and eigen vector matrix of the covariance matrix (A) using the  
             characteristic equation: 
               0 xIA            (6)                
             Where,  = eigen-values and  x is the eigen vector associated with eigen value   





I = Identity matrix. 
Step 6: Sort  in ascending order for eigen decomposition. Calculate the eigen vector with highest eigen value 
             which is called the principal component of the data sets and formed a feature vector(matrix of vector) 
             based on this eigen values: 






eig           (7) 
Step 7: To differentiate cancer and normal cells using feature vectors, a new Final Data matrix (1 ) is created 
             and plot the Final Data with respect to length of the  sequence: 
              Final Data (k) = M T * [Xnew, Ynew]         (8)                
The algorithm is tested on several databases as shown in [Table 2]. 
 
4. Result and Discussion 
    
In this present PCA model, correlation coefficients have been calculated between (8 normal × 8 cancer) prostate 
cells and (8 normal × 8 normal) prostate cells, are shown in [Table 3] and [Table 4]. PCA analysis shows all positive 
correlation coefficients, when normal prostate databases compared with other normal prostate databases. Therefore, 
the correlation between them is high or they are similar cells. Whereas when normal prostate cell compared with the  
cancerous prostate cells, out of 64 combinations, 63 shows negative value, means they are orthogonal or 
uncorrelated samples. One cross-correlation shows positive value that means error is only 0.8% in this present 
comparative study. The model proposed in this article will be suitable for preliminary prediction of cancer and 
normal cells and the algorithm is tested in MATLAB environment. The correlation coefficients obtained from the 
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PCA model for normal vs. cancer and normal vs. normal cells are depicted in Table 3 and Table 4 respectively. Due 
to space constraint, only some of the simulated plots for the comparative analysis are displayed in Fig.3 and Fig.4. 
Researchers [14-17] are used mostly PCA tool for classification of protein structures or to detect different features 
of breast cancers. The application of PCA technique for differentiating prostate cancer cells from normal prostate 
cells is new approach in the recent research.  
 
 








    
     

























   N O R M A L  
 Accession no. AF224278.1 AF331165.1 AF462605.1 M15885.1 M24543.1 M24902.1 NM005984.3 NM007003.2 
 AF224278.1 * 28.8641 15.1526 15.2976 14.9434 23.0799 17.6268 15.3736 
N AF331165.1 28.8641 * 7.8845 7.1685 16.0727 24.6303 18.96 6.4127 
O AF462605.1 15.1526 7.8845 * 7.4782 15.3553 23.6554 17.8473 7.801 
R M15885.1 15.2976 7.1685 7.4782 * 15.4648 23.8892 18.4618 7.143 
M M24543.1 14.9434 16.0727 15.3553 15.4648 * 22.6466 17.0991 15.5635 
A M24902.1 23.0799 24.6303 23.6554 23.8892 22.6466 * 22.2841 24.0479 
L NM005984.3 17.6268 18.96 17.8473 18.4618 17.0991 22.2841 * 18.399 
 NM007003.2 15.3736 6.4127 7.801 7.143 15.5635 24.0479 18.399 * 
 
   C A N C E R  
 Accession no. AAQ08976.1 AF304370.1 AF338650.1 AF455138.1 AY008445.1 FJ649644.1 NP001035756.1 NP001231873.1 
 AF224278.1 -26.0477 -48.4853 -161.8877 -27.7271 -27.8535 -29.0009 -26.0555 -27.8534 
N AF331165.1 -27.7015 -51.6589 -170.885 -29.5669 -28.6867 -30.8476 -27.7092 -29.6863 
O AF462605.1 -26.4612 -49.5525 -165.2082 -28.22 -28.3435 -29.5763 -26.469 -28.3428 
R M15885.1 -27.1346 -50.3156 -167.4919 -28.6605 -28.7839 -29.8534 -27.1425 -28.7852 
M M24543.1 -25.3429 -47.4 -158.5457 -27.0901 -27.2194 -28.4354 -25.3509 -27.2198 
A M24902.1 -26.5532 -49.3816 -163.3887 -28.2532 -28.3769 -29.5725 -26.5608 -28.3768 
L NM005984.3 -26.9842 -50.3914 -166.5609 -28.832 -28.9521 -30.0249 -26.9919 -28.9508 
 NM007003.2 -24.8987 -47.0019 -156.3431 -26.5466 -26.6784 27.9601 -24.9068 -26.6785 
 
Type of cell Accession Number 
Normal Prostate 
Cell 
AF224278.1, AF331165.1, AF462605.1, M15885.1, M24543.1, M24902.1, NM_005984.3, NM_007003.2 
Prostate Cancer 
Cell 
AAQ08976.1, AF304370.1, AF338650.1, AF455138.1, AY008445.1, FJ649644.1, NP001035756.1, NP001231873.1 
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Fig.3. DFT and PCA of (a) AF224278.1 (normal) vs. AF331165.1 (normal); (b) M24543.1 (normal) vs. M24902.1(normal); (c) AF224278.1 
(normal) vs. AAQ08976.1(cancer); (d) M24543.1(normal) vs. AY008445.1(cancer). 
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Fig. 4. DFT and PCA of (a) AF462605.1(normal) vs. M15885.1(normal); (b) NM_005984.3(normal) vs. NM007003.2(normal); (c) AF462605.1 





    The PCA model in this article is tested successfully on prostate cells only. Further cells will be taken as sample 
databases (e.g. breast, skin, pancreas, lung) in future for prediction of cancers. Canonical Correlation Analysis 
(CCA) may also be used for future study . But in the present study, we restrict analysis only in PCA because our 
main target is to separate out cancer associated prostate cells from the normal prostate cells. PCA works better in 
this perspective as analysis is based on maximum variance between the samples whereas CCA analysis is based on 
maximum correlation between the datasets. In this present era genomics research is not only limited to wet smelly 
laboratory. Soft databases are available in public domain [18], scientist from different fields may use their expertise 
for analysis and diagnosis of genetic diseases. 
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